Long-time patient rights advocate Kathryn Tucker, then Special Counsel at Emerge Law Group, now Special Advocacy Advisor at the National Psychedelics Association submitted a Freedom of Information Act (“FOIA“) request to the Drug Enforcement Administration (“DEA“) on March 31, 2022 on behalf of the Seattle area palliative care clinician Dr. Sunil Aggarwal of the Advanced Integrative Medical Science (“AIMS”) Institute, and several of his patients with terminal cancer. The FOIA Request seeks documents bearing on the DEA’s handling of Dr. Aggarwal’s Request for Waiver and a Petition to Reschedule psilocybin from Schedule I to Schedule II of the federal Controlled Substances Act. Delay appears to be the DEA’s standard course of action, but in this case where the interests of dying patients are at stake such delay is unacceptable.
Let us know what you think